Over 30 people across four states have been poisoned by bacterial toxins after receiving IV drips containing glutathione from wellness clinics. The Centers for Disease Control and Prevention and the Food and Drug Administration (FDA) have found that the glutathione was made from dietary supplement grade powders, labeled as inappropriate for injectable drugs. This incident raises serious concerns about the safety and regulation of IV drip treatments offered in wellness clinics.

Glutathione, a naturally occurring antioxidant, has been marketed for detoxification, immune support, increased energy, and skin brightening. However, its use in IV drips has been problematic due to the difference in grading between dietary supplements and sterile injectable drugs. The FDA has warned that Medisca Inc., the manufacturer, had instructed its pharmacy customers not to use the product for injectable purposes, but the warning came too late for the 30 people who fell ill.

The incident highlights the risks associated with unregulated compounding pharmacies and the potential for serious harm when treatments are not properly regulated. The FDA has called for increased scrutiny and oversight of such practices to prevent future incidents.

For now, the takeaway is clear: before seeking out IV treatments, it is crucial to ensure that the provider is using FDA-approved products and adheres to strict safety protocols.